|Faruqi & Faruqi, LLP|
|369 Lexington Avenue, 10th Floor|
|New York, NY 10017|
|Attn: Juan E. Monteverde, Esq.|
|Toll Free: (877) 247-4292|
|Phone: (212) 983-9330|
Roche's purchase of Anadys provides the third drug in what may be the first all-oral hepatits C regimen to start late-stage trials.
Roche buys Anadys for $230 million as large drug makers seek new drugs for combination therapy against hepatitis C.